Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation

Human epidemiological evidence and animal experimental data suggest that chronic manganese (Mn) exposure increases the risk of Alzheimer’s disease (AD) and amyloid plaques, a hallmark of AD brain pathology, but the underlying mechanisms were not fully understood. Using the transgenic APP/PS1/Tau tri...

Full description

Bibliographic Details
Main Authors: Geng Lin, Xinlu Li, Xiaofeng Cheng, Ning Zhao, Wei Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.556008/full
_version_ 1828787297154236416
author Geng Lin
Xinlu Li
Xiaofeng Cheng
Ning Zhao
Wei Zheng
author_facet Geng Lin
Xinlu Li
Xiaofeng Cheng
Ning Zhao
Wei Zheng
author_sort Geng Lin
collection DOAJ
description Human epidemiological evidence and animal experimental data suggest that chronic manganese (Mn) exposure increases the risk of Alzheimer’s disease (AD) and amyloid plaques, a hallmark of AD brain pathology, but the underlying mechanisms were not fully understood. Using the transgenic APP/PS1/Tau triple transgenic AD (3×Tg-AD) mouse model and mouse-derived microglia and neuroblastoma cell lines, we found that chronic 5-month Mn treatment increased beta amyloid peptide (Aβ) expression and Aβ plaques in the cerebral cortex and hippocampus in these 3×Tg-AD mice. Furthermore, we found that the β- and γ-secretase cleavage activities were markedly increased, while α-secretase cleavage activity was reduced in the brain of Mn-treated AD mice; these effects increase Aβ production and thus are amyloidogenic. Equally important, Mn treatment alone did not alter β-secretase 1 (BACE1) gene expression or Aβ production in amyloidogenic mutant amyloid precursor protein (APP) gene hAPPsw-transfected N2a cells (APPsw-N2a), but in APPsw-N2a cells either co-cultured with microglia or cultured with microglia-conditioned media, Mn exposure increased BACE1 expression and amyloidogenesis. We further determined that Mn exposure promoted the activation of microglia both in 3×Tg-AD mouse brains and in cultured microglia cells, and increased the secretion of the inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). Taken together, these results suggest that Mn may increase the release of IL-1β and TNF-α from microglia that in turn stimulates the expression of BACE1 gene and protein and consequently Aβ production; this novel molecular mechanism not only advances our understanding about the amyloidogenic effect of chronic Mn exposure reported for special human populations but also indicates Mn dyshomeostasis as a potential contributor to AD pathogenesis.
first_indexed 2024-12-12T00:28:49Z
format Article
id doaj.art-c66c97237ad14fcaa321d1253b151c8d
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-12-12T00:28:49Z
publishDate 2020-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-c66c97237ad14fcaa321d1253b151c8d2022-12-22T00:44:33ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-11-011210.3389/fnagi.2020.556008556008Manganese Exposure Aggravates β-Amyloid Pathology by Microglial ActivationGeng Lin0Xinlu Li1Xiaofeng Cheng2Ning Zhao3Wei Zheng4Department of Histology and Embryology, China Medical University, Shenyang, ChinaDepartment of Histology and Embryology, China Medical University, Shenyang, ChinaDepartment of Histology and Embryology, China Medical University, Shenyang, ChinaShengjing Hospital of China Medical University, Shenyang, ChinaDepartment of Histology and Embryology, China Medical University, Shenyang, ChinaHuman epidemiological evidence and animal experimental data suggest that chronic manganese (Mn) exposure increases the risk of Alzheimer’s disease (AD) and amyloid plaques, a hallmark of AD brain pathology, but the underlying mechanisms were not fully understood. Using the transgenic APP/PS1/Tau triple transgenic AD (3×Tg-AD) mouse model and mouse-derived microglia and neuroblastoma cell lines, we found that chronic 5-month Mn treatment increased beta amyloid peptide (Aβ) expression and Aβ plaques in the cerebral cortex and hippocampus in these 3×Tg-AD mice. Furthermore, we found that the β- and γ-secretase cleavage activities were markedly increased, while α-secretase cleavage activity was reduced in the brain of Mn-treated AD mice; these effects increase Aβ production and thus are amyloidogenic. Equally important, Mn treatment alone did not alter β-secretase 1 (BACE1) gene expression or Aβ production in amyloidogenic mutant amyloid precursor protein (APP) gene hAPPsw-transfected N2a cells (APPsw-N2a), but in APPsw-N2a cells either co-cultured with microglia or cultured with microglia-conditioned media, Mn exposure increased BACE1 expression and amyloidogenesis. We further determined that Mn exposure promoted the activation of microglia both in 3×Tg-AD mouse brains and in cultured microglia cells, and increased the secretion of the inflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α). Taken together, these results suggest that Mn may increase the release of IL-1β and TNF-α from microglia that in turn stimulates the expression of BACE1 gene and protein and consequently Aβ production; this novel molecular mechanism not only advances our understanding about the amyloidogenic effect of chronic Mn exposure reported for special human populations but also indicates Mn dyshomeostasis as a potential contributor to AD pathogenesis.https://www.frontiersin.org/articles/10.3389/fnagi.2020.556008/fullAlzheimer’s diseaseβ-amyloidmicrogliamanganeseneuroinflammationcytokines
spellingShingle Geng Lin
Xinlu Li
Xiaofeng Cheng
Ning Zhao
Wei Zheng
Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
Frontiers in Aging Neuroscience
Alzheimer’s disease
β-amyloid
microglia
manganese
neuroinflammation
cytokines
title Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
title_full Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
title_fullStr Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
title_full_unstemmed Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
title_short Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
title_sort manganese exposure aggravates β amyloid pathology by microglial activation
topic Alzheimer’s disease
β-amyloid
microglia
manganese
neuroinflammation
cytokines
url https://www.frontiersin.org/articles/10.3389/fnagi.2020.556008/full
work_keys_str_mv AT genglin manganeseexposureaggravatesbamyloidpathologybymicroglialactivation
AT xinluli manganeseexposureaggravatesbamyloidpathologybymicroglialactivation
AT xiaofengcheng manganeseexposureaggravatesbamyloidpathologybymicroglialactivation
AT ningzhao manganeseexposureaggravatesbamyloidpathologybymicroglialactivation
AT weizheng manganeseexposureaggravatesbamyloidpathologybymicroglialactivation